Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tyrosine kinase inhibitors, their preparation and use covered by Merck patent

Dec. 19, 2003

Sosei and Nippon Organon to copromote SOT-375 in Japan

Dec. 18, 2003

Efficacy and safety of lonafarnib in hematological tumors

Dec. 18, 2003

Antitumor effects of CCI-779 in multiple myeloma and MCL

Dec. 18, 2003

Phase I trial of topotecan TCS delayed until Q3 2004

Dec. 18, 2003

New findings on structure and function of prostate-specific membrane antigen

Dec. 17, 2003

Valera files Vantas NDA

Dec. 17, 2003

Independent committee recommends early end to phase III Velcade trial

Dec. 17, 2003

Japanese rights to bevacizumab and pertuzumab licensed to Chugai

Dec. 17, 2003

Targent acquires dibromodulcitol

Dec. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...